- Home
- RNA vs RHI Comparison
RNA vs RHI Comparison
Compare RNA & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- RHI
- Stock Information
- Founded
- RNA 2012
- RHI 1948
- Country
- RNA United States
- RHI United States
- Employees
- RNA N/A
- RHI N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- RHI Professional Services
- Sector
- RNA Health Care
- RHI Consumer Discretionary
- Exchange
- RNA Nasdaq
- RHI Nasdaq
- Market Cap
- RNA 4.0B
- RHI 4.1B
- IPO Year
- RNA 2020
- RHI N/A
- Fundamental
- Price
- RNA $46.92
- RHI $36.32
- Analyst Decision
- RNA Strong Buy
- RHI Hold
- Analyst Count
- RNA 15
- RHI 5
- Target Price
- RNA $68.40
- RHI $49.80
- AVG Volume (30 Days)
- RNA 3.7M
- RHI 2.0M
- Earning Date
- RNA 08-07-2025
- RHI 07-23-2025
- Dividend Yield
- RNA N/A
- RHI 6.53%
- EPS Growth
- RNA N/A
- RHI N/A
- EPS
- RNA N/A
- RHI 1.75
- Revenue
- RNA $10,729,000.00
- RHI $5,569,026,000.00
- Revenue This Year
- RNA N/A
- RHI N/A
- Revenue Next Year
- RNA $196.18
- RHI $3.51
- P/E Ratio
- RNA N/A
- RHI $20.61
- Revenue Growth
- RNA 1.23
- RHI N/A
- 52 Week Low
- RNA $21.51
- RHI $33.18
- 52 Week High
- RNA $56.00
- RHI $78.41
- Technical
- Relative Strength Index (RSI)
- RNA 71.22
- RHI 43.98
- Support Level
- RNA $45.06
- RHI $33.18
- Resistance Level
- RNA $47.24
- RHI $36.66
- Average True Range (ATR)
- RNA 2.58
- RHI 1.09
- MACD
- RNA 0.50
- RHI 0.21
- Stochastic Oscillator
- RNA 81.95
- RHI 56.62
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.